Literature DB >> 1056279

Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.

G Leonetti, G Mayer, A Morganti, L Terzoli, A Zanchetti, G Bianchetti, E Di Salle, P L Morselli, C A Chidsey.   

Abstract

1. In patients with mild or moderate essential hypertension, oral propranolol, given in incremental doses, produced a moderate but significant lowering of blood pressure which was correlated with the concentration of propranolol in plasma. 2. Propranolol also reduced plasma renin activity (PRA) in the supine posture, on standing and after intravenous frusemide. However, 'supine' and 'frusemide' PRA values were markedly reduced at a plasma concentration of propranolol that had little effect on blood pressure. 3. On administration of propranolol there was little correlation between blood pressure decrease and PRA suppression, and even less between pretreatment PRA values and hypotensive response. 4. It is concluded that in patients with mild and moderate hypertension and low or normal plasma renin activity, suppression of PRA is not an important determinant of the hypotensive response to propranolol.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1056279     DOI: 10.1042/cs0480491

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  36 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

Review 2.  Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect?

Authors:  J Hamer
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

3.  The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.

Authors:  G S Stokes; R M Graham; M A Weber
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

Review 5.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

6.  Hospital-acquired hyperkalaemia.

Authors:  N C Bacon
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

7.  [Behaviour of plasma renin activity during long-term treatment with propranolol (author's transl)].

Authors:  H Witzgall; D Klaus; B Braun; H Ebel; J Zehner
Journal:  Klin Wochenschr       Date:  1977-04-01

8.  Pharmacokinetics of propranolol in normal healthy volunteers.

Authors:  R Gomeni; G Bianchetti; R Sega; P L Morselli
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

Review 9.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

10.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M L Orme; M D Rawlins; J Ostman
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.